← Open Payments lookup

ANNE SMREK: Open Payments

NPI 1467006460 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,053 in 46 payments from 15 companies in 2025. Trend: 2023 $1,242 · 2024 $1,905 · 2025 $1,053

Food & beverage: $1,053
CompanyPaymentsAmount
Janssen Biotech, Inc.6$206
ABBVIE INC.8$174
Takeda Pharmaceuticals U.S.A., Inc.7$137
Madrigal Pharmaceuticals4$98
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$98
Regeneron Healthcare Solutions, Inc.2$53
Ardelyx, Inc.3$50
Phathom Pharmaceuticals, Inc.2$43
PFIZER INC.2$42
Celltrion USA Inc.2$39

Products named: TREMFYA, REZDIFFRA, XIFAXAN, DUPIXENT, EOHILIA, RINVOQ, SKYRIZI, ENTYVIO.

Industry payments across IN — which companies pay providers there.